Hacker News new | past | comments | ask | show | jobs | submit login

Because it’s under patent.

There was a temporary allowance for compounding it due to sustained manufacturer shortages but that is in the process of expiring.






Wasn’t GLP-1 discovered in 1984?

The first generation drug Exenatide's patent was filed in 1992, but got approved in 2005. The latest one is Tirzepatide, a dual agonist, approved in 2022. Expect soon for Retaglutide, a triple agnonist, in the market.

Not the newer ones that have lower risks of lifetime digestive issues.

As far as we know.



Join us for AI Startup School this June 16-17 in San Francisco!

Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: